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Background: Yeast Saccharomyces cerevisiae is a widely-used system for protein expression. We previously showed
that heat-killed whole recombinant yeast vaccine expressing mammalian myostatin can modulate myostatin
function in mice, resulting in increase of body weight and muscle composition in these animals. Foreign DNA
introduced into yeast cells can be lost soon unless cells are continuously cultured in selection media, which usually
contain antibiotics. For cost and safety concerns, it is essential to optimize conditions to produce quality food and
pharmaceutical products.
Results: We developed a simple but effective method to engineer a yeast strain stably expressing mammalian
myostatin. This method utilized high-copy-number integration of myostatin gene into the ribosomal DNA of
Saccharomyces cerevisiae. In the final step, antibiotic selection marker was removed using the Cre-LoxP system to
minimize any possible side-effects for animals. The resulting yeast strain can be maintained in rich culture media
and stably express mammalian myostatin for two years. Oral administration of the recombinant yeast was able to
induce immune response to myostatin and modulated the body weight of mice.
Conclusions: Establishment of such yeast strain is a step further toward transformation of yeast cells into edible
vaccine to improve meat production in farm animals and treat human muscle-wasting diseases in the future.
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Yeast Saccharomyces cerevisiae is a widely-used protein
expression system to produce target proteins of great
commercial value [1]. Such protein products include not
only food or food supplements for human and animal
consumption, but also varieties of non-food industrial
products for the ultimate benefit of mankind.
Myostatin (MSTN), also known as growth and differ-
entiation factor 8 (GDF8) is a member of transforming
growth factor (TGF)-ß superfamily, which has been
found to be capable of modulating the body weight
and muscle composition in laboratory and farm ani-
mals [2-5]. In a recent proof-of-concept study, we
demonstrated that oral feeding of heat-killed whole re-
combinant yeast Saccharomyces cerevisiae expressing* Correspondence: zhangzhy@nwsuaf.edu.cn
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reproduction in any medium, provided the ormammalian myostatin from a plasmid elicited antigen-
specific cell and humor responses, which resulted in
increased body weight and muscle composition in mice
[6]. Due to its simple growing method and nontoxic
nature, it is reasonable to believe that such recombin-
ant yeast can be further developed into edible vaccine,
which is useful to improve meat production in farm
animals and combat human muscle-wasting diseases
such as muscular atrophy.
Yeast can be easily transformed with foreign DNA,
which carries gene expression cassette. However, once in
cells, the foreign DNA, which is often in a form of episo-
mal plasmid, can be easily lost after a couple of rounds
of cell replication unless selection pressure is continu-
ously applied. On the other hand, to maintain the for-
eign DNA in cells expression of antibiotic selection
marker and/or addition of antibiotics in culture may not
be favorable for the purpose of protein production either
for human consumption or for pharmaceutical use.
Auxotrophic complementary selection markers haveLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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remains inconvenient and costly to grow a strain with
synthetic media by using these markers. To date,
chromosomal integration of gene expression cassette in
yeast cells offers a better choice to avoid most of the pro-
blems mentioned above. Chromosomal integration can
lead to a stable expression and eliminate the need of se-
lection pressure to maintain an established recombinant
yeast strain. Here, we presented our results of engineer-
ing a yeast strain, which carries chromosomal integration
of mammalian myostatin expression cassette, and stably
produces myostatin protein shown by western blot.
Moreover, with the help of the Cre-LoxP system we
removed the selection marker gene which is absolutely
nonessential for expression of target proteins.
Results
Construction of integration plasmids
The intermediate plasmids pBlue-KanMX4 and pBlue-
KanMX4-NTS2-5’3’ were constructed as described in
Materials and Methods. Meanwhile, we constructed
myostatin expression cassette using overlap PCR strat-
egy. To do so, PCR primers were designed to first amp-
lify the promoter region of ADH1 gene using ADH1-F
and ADH1-R primers from yeast expression vector
JMB667 (a gift from Dr. Mymryk), the termination re-
gion of CYC3 gene using CYC3-F and CYC3-R primers
from the same yeast expression vector as for amplifica-
tion of ADH1 promoter (Table 1), the coding region of
porcine myostatin cDNA using MSTN-F and MSTN-R
primers from JMB88-MSTN previously described in our
studies [6]and . The PCR products of these three regions
were 1420 bp, 260 bp and 1128 bp, respectively
(Figure 1A). After gel purification, 1 ul each of these
three DNA fragments mixed with ADH1-F and CYC3-R
primers were used for overlapping PCR as described in













MSTN-R CATAACmyostatin expression cassette was about 2880 bp in
length (Figure 1B). Then, the DNA fragment of PCR
product was recovered, digested with XhoI and EcoRI,
and subcloned into pBlue-KanMX4-NTS2-5’3’ on the
same restriction sites. The resulting final plasmid was
designated as pBlue-KanMX4-NTS2-5’3’-MSTN. The
success of subcloning was confirmed by restriction di-
gestion (Figure 1C) and by DNA sequencing (data
not shown). A schematic illustration map of integra-
tion plasmid is given in Figure 1D.
Chromosomal integration of target plasmid in yeast
JMY1To integrate target plasmid into chromosomes of
yeast, we followed a standard procedure of homologous
DNA recombination. In brief, pBlue-KanMX4-NTS2-
5’3’-MSTN plasmid was linearized by restriction diges-
tion with KpnI. Then, DNA fragment was gel-purified
and used to transform yeast JMY1. Transformants were
grown on YEPD rich medium agar plates containing 200
μg/ml of G418 at 30°C. Three days later, nearly a hun-
dred positive colonies showed up on the plate, and three
of them were randomly selected and amplified in fresh
YEPD liquid media. Genomic DNA was extracted using
the method described by Harju et al. [7]. It involved
repeated freeze-thawing of cells in a lysis buffer to dis-
rupt cell wall and membrane and release their genomic
DNA. Isolated DNA was resuspended in TE buffer and
further diluted to 200ug/ml. One μl of such prepared
genomic DNA solution was used and subjected to PCR
using CYC3-F and NTS2-3’-R primers as previously
described (Table 1). Since the target plasmid had been
linearized prior to transformation, it would not propa-
gate along with cell replication, which rendered negative
results for those cells without chromosomal integration.
As shown in Figure 2A, two of the three colonies gave
rise to an 1826-bp PCR product, indicating that the tar-
get plasmid had been successfully integrated into the
chromosomes of these cells. Both colonies were thenre)













Figure 1 Construction of integrate plasmid pBlue-KanMX4-NTS2-5’3’-MSTN. (A) PCR amplification of ADH1 promoter (ADH1 p), Cyc3
termination signal (Cyc3 term) and the cDNA of myostatin (MSTN cDNA). (B) Overlapping PCR for myostatin expression cassette. (C) Restriction
digestion of pBlue-KanMX4-NTS2-5’3’-MSTN with enzymes indicated in the figure. In panels (A) - (C), DNA fragments were separated in 1%
agarose gel and visualized by ethidium bromide staining. DNA molecular weight marker was shown in lane 1. (D) Schematic illustration of
integrate plasmid pBlue-KanMX4-NTS2-5’3’-MSTN.
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designated JMY11 and used in further studies.
Removal of KanMX4 marker gene
Regardless its molecular mechanism, retaining a selec-
tion marker gene in yeast cells would have potential
deleterious effect on the production of target gene prod-
uct. Towards a step further to transform yeast into ed-
ible vaccine, we decided to remove the KanMX4
selection module after the chromosomal integration of
myostatin gene expression cassette was confirmed. A
Cre gene expression plasmid JMB943 was transformed
into JMY11, and grew in minimal SD plate depleted of
uracil for 96 hours. Then, four colonies were randomly
selected and tested for the removal of KanMX4 module
by PCR using primers CYC3-F and NTS-3’-R (Table 1).Compared to negative control, all four colonies showed
a PCR product in the size of 346 bp (Figure 2B), indicat-
ing that KanMX4 module was removed. To further con-
firm removal of KanMX4 module, we tested these cells
on G418 selection media and did not find the cells grew
on G418 media (data not shown). These colonies were
preserved in glycerol solution at −80°C, and then used in
further studies.
Expression of myostatin in yeast cells
Finally, we examined the expression of recombinant
mammalian MSTN in newly established yeast strain. All
four colonies obtained from last step were grown in
5 ml of YEPD rich media at 30°C for 24 hours. Subse-
quently, yeast whole protein was extracted using LiAc/
NaOH extraction methods, which was invented in our
Figure 2 Construction of recombinant yeast strain JMY12. (A) JMY11: The success of chromosomal integration in two randomly selected
yeast transformants was confirmed by PCR using primers Cyc3-F and NTS2-3’-R. (B) JMY12: Removal of KanMX4 expression cassette was
confirmed by PCR using the same primers for identification of yeast strain JMY11. Four randomly selected yeast colonies were shown in lanes
2–4. A negative control was shown in lane 6. In both (A) and (B), DNA fragments were separated in 1% agarose gel and visualized by ethidium
bromide staining. Lane 1: DNA molecular weight marker.
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out using home-made mouse polyclonal anti-MSTN
antibody. Meanwhile, we used yeast cells expressing
MSTN from a plasmid with Cu2+-inducible promoter as
positive control. As shown in Figure 3A, a colony that
carried chromosomal integration of MSTN gene and sta-
bly expressed MSTN protein had similar expression effi-
ciency as that of inducible promoter. The strain derived
from this colony was designated JMY12 and used in fur-
ther studies. All other colonies expressed MSTN to simi-
lar levels with little differences (data not shown).
To test the stability of newly established yeast strain
JMY12 which kept at −80°C for 2 years, we first recov-
ered the strain JMY12 and cultured the cells in largescale for the strain stability test and oral immunization.
After starting immunization experiment, we had main-
tained the recombinant strain in rich media for 6 months
and then checked the stability every 12 hours for 10 days.
Compared to protein samples previously prepared, our
results showed that expression of recombinant mamma-
lian myostatin in JMY12 was stable after long period of
culture in rich media (Figure 3B).
Effect of whole recombinant yeast vaccine on the body
weight of mice
The vaccination procedure carried out in this study
lasted a total of 5 weeks, but the mice were maintained
for additional 7 weeks before they were sacrificed.
Figure 3 Analysis of MSTN expression in yeast strain JMY12 by western blotting. (A) A negative control from parental yeast strain JMY1
and a positive control of MSTN expression from Cu2+-inducible promoter were shown in lanes 1 and 2, respectively. Expression of MSTN from
yeast strain JMY12 was shown in lane 3. In upper panel, MSTN expression was revealed by mouse polyclonal anti-MSTN antibody. In lower panel,
western blotting for ß-actin was performed to ensure the equal loading of protein samples. (B) JMY12 stored for two years and recovered for the
western blotting. In upper panel, MSTN expression was revealed by mouse polyclonal anti-MSTN antibody. In lower panel, western blotting for
ß-actin was performed to ensure the equal loading of protein samples.
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tion of anti-MSTN antibody in mouse serum. As shown
in Figure 4, the mice immunized with the yeast strain
stably expressing MSTN generated specific anti-MSTN
antibody in their serum, but not detected in control
group. We then examined the body weight of each ani-
mal both before and after the experiment. As shown in
Table 2, when the experiment started all mice were
about the same size with little difference. At the end of
experiment, however, they weighted from 39 to 42 g and
the average sizes varied among groups. In group PBS
and group JMY1, the average increase of body weight
was 16.916 ± 0.096 or 16.856 ± 0.177 g, respectively,
whereas it was 19.326 ± 0.428 g in group JMY12, sug-
gesting that vaccination against myostatin modulated the
body weight of animals and oral administration of whole
recombinant yeast vaccine was effective.
Discussion
In this study, we engineered a yeast strain from Sac-
charomyces cerevisiae, which carries chromosomal inte-
gration of mammalian myostatin expression cassette
and is capable of stably expressing the target protein
in rich culture media without the need of maintaining
selection pressure. An ideal yeast vaccine candidate
should be free of antibiotic selection marker genes and
easily for growing in rich media without selection
pressure. We constructed such recombinant yeast
strain, which could be used for a large scaleFigure 4 Detection of myostatin-specific antibodies in mice serum. A
(serum samples from group PBS, JMY1, JMY12, respectively) was shown. Sepreparation of edible vaccine for animals based on the
functional analysis of mammalian myostatin in our
previous report [6].
To ensure the expression of target protein perman-
ently, we chose the non-transcriptional spaces of yeast
rRNA gene as chromosomal integration sites. Alterna-
tively, chromosomal integration might be also achieved
by using homologous sequences to yeast chromosomal
centromere or telomere regions [9]. However, the copy
numbers of these integration sites are often limited to
one per cell. Recent studies have shown that the non-
transcribed spacers, NTS1 and NTS2, in the 5’ and 3’
end flanking regions of 5S ribosomal DNA, which separ-
ate from its upstream and downstream ribosomal RNA
precursor-encoding genes are the ideal sites for chromo-
somal integration [5,10]. They are highly conservative
and each offers approximately 150 copies per cell in
yeast Saccharomyces cerevisiae. The actual copy number
of myostatin expression cassette in our yeast can be
examined by Southern blotting or in situ hybridization,
but it was not determined in this study due to the lack
of appropriate lab equipments and technique. Nonethe-
less, western blotting analysis provided a satisfactory re-
sult when compared to a MSTN-plasmid expressing
strain, which was previously established and used in our
lab (Figure 3A). And the new strain could stably express
MTSN in rich culture after stored for two years
(Figure 3B). We confirmed that similar levels of expres-
sion of MSTN to this yeast were capable of giving rise torepresentative western blot from three independent experiments
rum dilution was 1:2000.
Table 2 Effect of immunization on the body weight of
micea
Group Before Immunization After Immunization Increase
PBS 22.926 ± 0.073 39.842 ± 0.862 16.916 ± 0.096
JMY1 22.864 ± 0.696 39.720 ± 0.784 16.856 ± 0.177
JMY12+ 22.354 ± 0.341 41.680 ± 0.768 19.326 ± 0.428*
a Mean ± standard deviation (g).
* Statistically significant difference (P < 0.05).
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affected their body weight.
The primary purpose of this study was to generate a
yeast strain, which stably expresses mammalian myosta-
tin in rich media. During the construction of integration
plasmid, we designed the intermediate vector pBlue-
KanMX4-NTS2-5’3’ in such a way that it may serve as a
unique chromosomal integration cloning vector for
other target proteins. The cloning sites are commonly
used restriction enzymes and can be further modified, if
necessary, for any cDNA subcloning task. Thus, this vec-
tor should be applicable to most protein expression in
yeast Saccharomyces cerevisiae and it is available for
other researchers on request.
Conclusions
The present study provides a convenient strategy to es-
tablish chromosomal integration of gene expression cas-
sette in yeast cells. The method is simple and easy to
perform. It combines previous research by others on
chromosomal integration and removal of KanMX4 selec-
tion cassette by Cre-LoxP procedure. The target gene
was mammalian myostatin whose expression was quite
successful and those recombinant yeast cells can induce
immune responses to myostatin by oral route, resulting
in increasing body weight in mice. It is an important
step towards transforming yeast cells into edible vaccine
to improve meat production in farm animals and combat
muscle-waste genetic diseases in human.
Methods
Animals
A total of 15 five-week-old male Kunming mice were
purchased from the Breeding and Research Center of
Xi'an Jiaotong University, China. Sterilized water and
food were provided ad libitum. All animal procedures
were performed in accordance with the policy and regu-
lations for care and use of laboratory animals. The ani-
mal experimental protocols were approved by the ethic
committee of Northwest A&F University before the start
of the experiments.
Yeast strain, media and culture conditions
A yeast Saccharomyces cerevisiae lab strain, JMY1
[MATα, his3-Δ 1 trp1-289 rad1-Δ ura3-52] wasroutinely cultured at 30°C in YEPD medium containing
1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glu-
cose. A derivative of yeast strain JMY1 containing the
vector that expresses Cu2+-inducible myostatin was
described in precious study [6]. In this strain, expression
of myostatin protein was induced by adding 0.5 mM of
copper sulphate in culture media when the optical dens-
ity (OD600) of cells reached 0.5 and continued growing
for 10 hours.
Yeast transformation
Plasmid vectors were introduced into yeast cells with
LiAc method as described by Gietz and Woods [11]. In
the present study, yeast transformants were immediately
selected on YEPD rich media plate supplemented with
200 μg/ml of G418.
Construction of integration plasmids
The antibiotic marker heterologous dominant KanMX4
module was chosen as the marker for the initial selec-
tion of transformation in yeast cells. First, we used the
genomic DNA of Yeast Homozygous Diploid Pools
(Cat#95401.H1Pool, Invitrogen, USA) as PCR template
and amplified a KanMX4 expression module 1526 bp in
length using primers LoxP-KanMX4-F and LoxP-
KanMX4-R. The primer sequences are shown in Table 1.
Then, the DNA fragment of PCR product was recovered,
digested with EcoRI and BamHI, and subcloned into
pBluescript II SK (+) at the same restriction sites. The
resulting plasmid was designated as pBlue-KanMX4.
To increase the chance and copy number of target
gene integrated into yeast chromosomes, we chose non-
transcriptional space 2 (NTS2) of yeast ribosomal RNA
(rRNA) gene as chromosomal integration sites. In this
regard, NTS2 region was added as the homologous arms
flanking MSTN expression cassette. To do so, DNA oli-
gomers were designed to cover the 5’ end (NTS2-5’-F
and NTS2-5’-R) and 3’ end (NTS2-3’-F and NTS2-3’-R)
of NTS2 region, respectively (Table 1). A pair of DNA
oligomers were annealed together carrying sticky ends
for subcloning into pBlue-KanMX4 plasmid at corre-
sponding restriction sites, i.e. KpnI and XhoI for NTS2-
5’, and NotI and SacII for NTS2-3’ ends. The resulting
plasmid was designated as pBlue-KanMX4-NTS2-5’3’.
Construction of MSTN expression cassette via overlapping
PCR
Prior to construction of myostatin expression cassette,
ADH1 promoter, CYC3 termination signal and the cod-
ing sequence of MSTN cDNA were amplified by stand-
ard PCR as previously described [6]. Each PCR fragment
was gel purified and measured for DNA concentration.
Next, 10 μM of each DNA segment were mixed with
DNA polymerase and dNTP in 1× reaction buffer, and
Zhang et al. BMC Biotechnology 2012, 12:97 Page 7 of 7
http://www.biomedcentral.com/1472-6750/12/97pre-incubated at 94°C for 5 min. Then, the reaction was
programmed at 94°C for 30 s, followed by annealing at
64°C for 30 s and primer extension at 72°C for 3 min
in initial cycle, and repeated for a total of 15 cycles. In
each consecutive cycle, the annealing temperature was
reduced 1°C. Subsequently, the program was set at
94°C for 30 s, 50°C for 30 s and 72°C for 3 min for a
total of 25 cycles. Finally, the reaction was extended at
72°C for 10 min. PCR product was gel-purified and
inserted into pBlue-KanMX4-NTS2-5’3’ at the site of
XhoI and EcoRI to obtain the final plasmid pBlue-
KanMX4-NTS2-5’3’-MSTN.
Western blotting
To examine myostatin expression in yeast, 5 ml yeast cul-
ture was collected and whole yeast cell extracts were pre-
pared by LiAc/NaOH extraction method [8]. Protein
samples were separated by SDS-polyacrylamide gel elec-
trophoresis (PAGE) and transferred onto nitrocellulose
membranes (Millipore, USA). Then, membranes were
incubated first with mouse polyclonal anti-myostatin anti-
body, and then horseradish peroxidase (HRP)-conjugated
goat anti-mouse IgG antibody. To ensure equal loading of
protein samples, mouse monoclonal anti-ß-actin antibody
was used for re-probe of the same membrane for myosta-
tin blotting. Signals were visualized by using enhanced
chemiluminescence (ECL, BoShiDe, China).
Immunization
Mice were divided into 3 groups with 5 individuals in
each group. The immunization protocol for groups was
as follows: mice in group PBS were orally fed with
100 μL of PBS weekly for 5 weeks and mice in group
JMY1 and JMY12 were orally fed with 1.2 × 108 heat-
killed whole recombinant yeast cells in 100 μL PBS
weekly for 5 weeks. After immunization, all mice were
maintained for additional 7 weeks. The whole experiment
lasted 12 weeks. The body weight of mice was recorded
weekly and serum samples were collected before
immunization and at the end of the experiment, and used
to determine the immune response with western blot.
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